0001628280-23-008354.txt : 20230316 0001628280-23-008354.hdr.sgml : 20230316 20230316174138 ACCESSION NUMBER: 0001628280-23-008354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230315 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erlander Mark CENTRAL INDEX KEY: 0001651537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 23740000 MAIL ADDRESS: STREET 1: C/O TROVAGENE, INC. STREET 2: 11055 FLINTKOTE AVENUE, SUITE A CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 4 1 wf-form4_167900288656705.xml FORM 4 X0306 4 2023-03-15 0 0001213037 Cardiff Oncology, Inc. CRDF 0001651537 Erlander Mark C/O CARDIFF ONCOLOGY, INC. 11055 FLINTKOTE AVE SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer Stock Options 1.72 2023-03-15 4 A 0 482064 0 A 2033-03-15 Common Stock 482064.0 1664477 D 25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person. /s/ Mark Erlander 2023-03-16